FDA Drug Recalls

4 recalls · Class I, newest first

Dec 21, 2023 Class I · High risk

Americaine

Chemical Contamination: presence of benzene

Completed Chemical / undeclared Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company NDC 63736-378-02 D-0236-2024

Nov 22, 2023 Class I · High risk

TING 2% Miconazole Nitrate Athlete's Foot Spray Antifungal Spray Powder

Chemical Contamination; presence of benzene.

Completed Chemical / undeclared Insight Pharmaceuticals Corporation D-0151-2024

Nov 17, 2023 Class I · High risk

Vigabatrin for Oral Solution

Defective Container: powder may leak out of the pouch

Completed Packaging defect InvaGen Pharmaceuticals, Inc. NDC 69097-964-53 D-0220-2024

Sep 25, 2023 Class I · High risk

Brexafemme

Cross Contamination with Other Products: Potential cross-contamination of ibrexafungerp citrate drug substance with ezetimibe (a non-antibacterial beta-lactam compound).

Completed Cross-contamination Scynexis, Inc. NDC 75788-115-04 D-0042-2024

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061